Ansofaxine hydrochloride (LY03005; LPM570065) 是三重重吸收抑制剂; 抑制血清素，多巴胺和去甲肾上腺素的 IC₅₀ 值分别为723，491 和 763 nM。

Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor; inhibits serotonin, dopamine and norepinephrine reuptake with IC 50 values of 723, 491 and 763 nM, respectively.

Solid

serotonin 723 nM (IC50) Dopamine Receptor

Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine. has not independently confirmed the accuracy of these methods. They are for r

Room temperature in continental US; may vary elsewhere.

4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

[1]. Zhang R, et al. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamineand norepinephrine levels in rats. PLoS One. 2014 Mar 10;9(3):e91775.

In Vitro: DMSO : 31.25 mg/mL (74.77 mM; Need ultrasonic)H₂O : 6.67 mg/mL (15.96 mM; ultrasonic and warming and heat to 60°C)配制储备液